MCG as a Noninvasive Diagnostic Strategy for Suspected INOCA (MICRO2)

Clinical trial NCT06212466 · COMPLETED

Trial details

NCT number: NCT06212466
Sponsor: Genetesis Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Ischemic Heart Disease Coronary Microvascular Disease Angina Myocardial Ischemia

Start date: 2024-06-03
Primary completion: 2025-04-15
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.